ABSTRACT

Congressional Budget Office Cost Estimate: Estimated Budgetary Effects of H.R. 7667, the Food and Drug Amendments of 2022 Act   [open pdf - 750KB]

From the Document: "H.R. 7667 would reauthorize the collection and spending of user fees by the Food and Drug Administration (FDA) for activities related to the approval and marketing of prescription drugs and medical devices. The bill also would amend the Federal Food, Drug, and Cosmetic Act in part to change processes and procedures for regulating, manufacturing, and marketing certain prescription drugs, medical devices, and other medical products."

Publisher:
Date:
2022-06-06
Copyright:
Public Domain
Retrieved From:
Congressional Budget Office: https://www.cbo.gov/
Format:
pdf
Media Type:
application/pdf
URL:
Help with citations